🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

"It's not only the responsibility of MTB and general surgeons to include a LS in the treatment planning for patients with stage IV CRC, but also the obligation of the LS to effectively communicate and make themselves available"Annals of Surgical Oncology American College of Surgeons

Most viewed in the last 7 days from JAMA Surgery: What are the rates and factors associated with a futile up-front pancreatectomy in patients with anatomically resectable pancreatic ductal adenocarcinoma? ja.ma/4fwrsAC

Do you know how many robotic hepatectomies you have to do before you overcome the learning curve? Check it out below⬇️ jogs.org/article/S1091-…

Initiation of a Robotic Pancreatoduodenectomy Program using Virtual Co... sciencedirect.com/science/articl…

Is it settled then? No role for neoadj RT in respectable gastric adenoCA, including GEJ (Siewert 2&3), not even with 2/3 of patients receiving periop ECF and not FLOT! TOPGEAR trial nejm.org/doi/full/10.10…

שנה. המילים לא יכולות למציאות. 🎗️ One year. Words fail to capture. #October7Massacre #BringThemHomeNow

Today JAMA Surgery: long term outcomes #ESCAPE RCT: early #surgery remains superior to #endoscopy in pts w/ wide-duct #chronic #pancreatitis (morphine-dependent) ✅ Lower Izbicki pain scores ✅ Lower number of reinterventions ✅ Lower VAS pain scores ✅ Higher patient

1st line Systemic Treatment for Initially Unresectable CRC Liver Mets JAMA Oncology doi.org/10.1001/jamaon… 🔎 Post Hoc of CAIRO5 Trial 👉no difference in OS between arms 👉excellent OS for pts w/ salvage local treatment in case of early recurrence ESMO - Eur. Oncology

Neoadjuvant chemotherapy for left 👈 sided resectable PDAC 🪡 72% of US received adjuvant 💉 NAT had better OS (53 🆚 37 months) 🤏 Tumor size and 🧪 elevated CA19.9 correlates with benefits of NAT And now… time for RCT! 💪 annalsofoncology.org/article/S0923-…

An honor and a privilege. HAIP coming soon to the Bronx.

Very true. Working towards change Montefiore Surgery surgical oncology and #MECCC

Successful first two cases of #HAIP at ⁦Montefiore Health System⁩. Great team work #MECCC. Great support from ⁦Montefiore Surgery⁩ leadership. This essential component of contemporary multidisciplinary care for CRLM & IHC is now available in the Bronx. linkedin.com/posts/montefio…

Adjuvant chemotherapy compared to observation in resected biliary tract cancers: Survival meta-analysis of phase-III controlled trials European J Cancer doi.org/10.1016/j.ejca… 👉4 trials: BILCAP, ASCOT, BCAT, PRODIGE-12 👉only ASCOT met 1° EP 🧐Not convincing, we need to do

Great time yesterday, talking about data on minimally invasive HPB surgery and program building at grand rounds Montefiore Surgery. Thanks for having me!

#ASCO2025 📢Practice changing for Biliary Tract and Gallbladder Cancers! GAIN trial Neoadjuvant chemo drastically improves outcomes in resectable BTC/GBC Phase III, randomized (N=68, stopped early due to accrual) Arm A: Gem/Cis ×3 → surgery → Gem/Cis ×3 Arm B: surgery →

The struggle is real. And CD grade 3 is enough to ruin my day.

Breaking news! Pump vs transplant is no longer a debate❤️. The parties (dr. Kingham and dr. Chapman) have come to agreement - transplant perfectly fits where #HAIP chemo fails. Ville Sallinen Grainne O'Kane can be congratulated as peacemakers #eahpba2025 Kristoffer Lassen Pål-Dag Line

🇨🇦 in #eahpba2025 champions league 🏆 HELIX RCT of TXA vs placebo for hepatectomy by Paul Karanicolas No change in 🩸transfusion but ⬆️ morbidity with TXA ⚠️ don’t use TXA for hepatectomy See 📝 JAMA 👉🏻 jamanetwork.com/journals/jama/…

Serum carbohydrate antigen 19-9 greater than 100 and risk of invasive carcinoma in pancreatic intraductal papillary mucinous neoplasms surgjournal.com/article/S0039-… superb SURGERY Journal study by Motaz Qadan, MD, PhD Max Servin-Rojas Raja Narayan, MD MPH Zhi Ven Fong, MD MPH DrPH Mass General Surgery Harvard Medical School Harvard University

Congratulations! Columbia Surgery and Cleveland Clinic won!